1-1 of 1
An Tran-Duy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased Eligibility for Attempting Treatment-Free Remission (TFR) with Frontline Nilotinib (NIL) vs Imatinib (IM) in Patients with Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia (CML): Results of a Stochastic Simulation Model

Francois-Xavier Mahon, MD PhD Professor, An Tran-Duy, Raechelle G. Ocampo, David Ray, PharmD, MBA, Estella Mendelson, BSRN, MBA, Aby Buchbinder, Pascal Edrich, Sonya J. Snedecor, PhD, Giuseppe Saglio
Journal: Blood
Blood (2015) 126 (23): 5154.
https://doi.org/10.1182/blood.V126.23.5154.5154
Published: 2015